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Abstract
Poor linkage, engagement and retention remain significant barriers in achieving HIV treatment 
goals in the US. HIV-infected persons entering or re-entering care across three Southern California 
academic HIV clinics, were randomized (1:1) to an Active, Linkage, Engagement, Retention and 
Treatment (ALERT) specialist for outreach and health coaching, or standard of care (SOC). The 
primary outcome of time to loss to follow up (LTFU) was compared using Cox proportional 
hazards regression modeling. No differences in the median time to LTFU (81.7 for ALERT versus 
93.6 weeks for SOC; HR 1.27; p = 0.40), or time to ART initiation was observed (N = 116). 
Although, ALERT participants demonstrated worsening depressive symptomatology from baseline 
to week 48 compared to SOC (p = 0.02). The ALERT intervention did not improve engagement 
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and retention in HIV care over SOC. Further studies are needed to determine how best to apply 
resources to improve retention and engagement.
Resumen
Pobre vinculación, la participación activa con el cuidado médico y la retención siguen siendo 
barreras significantes para lograr los objetivos de tratamiento del VIH en los Estados Unidos. Las 
personas infectadas por el VIH que ingresan o reingresan a la atención medica en tres clínicas 
académicas de VIH del sur de California, aleatorizado (1:1) a un Active, Linkage, Engagement, 
Retention and Treatment (ALERT) especialista para alcance y educación de salud, o estándar de 
atención (SOC). Se comparó el resultado primario del tiempo hasta la pérdida de seguimiento 
(LTFU) usando modelado de regresión de riesgos proporcionales Cox. No hubo diferencias en el 
tiempo mediano para LTFU (81,7 para ALERT versus 93,6 semanas para SOC; HR: 1.27; p = 
0.40), tampoco en el tiempo de iniciación los medicamentos del VIH (N = 116). Los participantes 
en el grupo de ALERT demostraron un empeoramiento de la sintomatología depresiva relativo a la 
línea basal hasta la semana 48 comparado al SOC (p = 0.02). La intervención ALERT no mejoro 
la participación activa y la retención en el cuidado del VIH sobre el SOC. Se necesita estudios 
adicionales para determinar la mejor manera de aplicar recursos para mejorar la retención y la 
participación activa.
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Introduction
HIV infection today is a manageable chronic illness when HIV-infected persons are engaged 
in care and adhere to antiretroviral therapy (ART). Of those living with HIV in the United 
States, 86% are diagnosed, 40% are engaged in care (defined as having one clinic visit or 
one laboratory for CD4/ HIV RNA within the last year), 37% are on ART, and 30% are 
virologically suppressed [1]. This “cascade of HIV care” identifies clear gaps in care 
delivery, from identifying HIV-infected people, to linking newly identified HIV-infected 
persons to a HIV clinic, retaining those persons in clinic, prescription of ART and 
optimizing adherence to ART [2]. In the United States, much effort has been placed on HIV 
testing, resulting in a decrease in the number of HIV-infected people who do not know their 
status from approximately 25% in the early 2000’s [3] to 14% in 2012 [4]. There has also 
been a lot of effort to link newly HIV-infected persons to care, yet as the cascade shows, 
only about 40% remain engaged in care. This is particularly important because poor 
engagement in care is associated with the majority of new HIV transmissions in the U.S [5].
Multiple factors contribute to poor engagement and retention in care for HIV-infected 
persons including low health literacy [6, 7], difficulty navigating health care [8, 9], HIV 
stigma [10–12], depression [13], substance use [14], and poor social support [15]. These 
barriers to care are common in HIV-infected persons [16–21] and associated with poorer 
psychosocial outcomes, changes in clinic site, lower CD4 counts, higher HIV viral loads, 
increased hospitalizations, and poorer self-reported health [10–12, 16, 18, 22–26]. African 
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American and Hispanic HIV-infected patients are particularly susceptible to barriers to care 
[27, 28] because of historically lower levels of health literacy [20, 21]. However, studies 
suggest that individual targeting of specific barriers to care can impact clinical outcomes. 
For example, improving health literacy promotes sustained increases in knowledge of ART 
and results in gains in CD4 T cell counts [23, 24]. Similarly, assisting with system 
navigation improves use of available resources, communication, and ultimately care 
engagement [29, 30].
Active participation of HIV-infected patients in their healthcare increases the likelihood of 
ART initiation, improves virologic response and lowers mortality [31–34]. Thus, several 
studies have utilized patient education, empowerment and facilitation of access to healthcare 
in an attempt to keep patients engaged in care but show mixed results [29, 35–37]. Project 
HOPE enrolled HIV positive patients who were recently hospitalized active drug users and 
used strength based and motivational interviewing to keep patients engaged in care [35]. In 
spite of extensive contact with the patient navigator and financial incentives given to 
participants, project HOPE did not impact lost to follow up (LTFU) rates. Other studies have 
successfully impacted LTFU rates with similar enhanced contact, skills building [36], and 
multidisciplinary care coordination teams [29, 37] that provided outreach, patient 
navigation, and ART directly observed therapy. Despite differing results, these studies 
suggest that to sustain meaningful engagement in HIV care amongst a diverse population of 
PLWH, requires addressing multiple barriers to care and very labor-intensive 
multidisciplinary team efforts. To determine if barriers to care can be overcome in a more 
time and cost-effective way, the California Collaborative Treatment Group (CCTG) designed 
a multi-site, structured behavioral intervention that targets multiple patient and clinic level 
factors to retention and engagement in HIV care that unlike previous studies utilized a single 
specialist. Specifically, CCTG 594 evaluated the impact of one-on-one coaching sessions 
delivered by an Active, Linkage, Engagement, Retention and Treatment (ALERT) specialist 
on engagement and retention in HIV care. We hypothesized that participants randomized to 
the ALERT arm would demonstrate higher levels of retention in care compared to subjects 
in the standard of care (SOC) arm.
Patient and Methods
Study Design
CCTG 594 (NCT01957748) was a two-arm, open-label, randomized controlled trial (RCT) 
evaluating the effect of an enhanced engagement and health coaching strategy using an 
ALERT specialist compared to SOC on retention in care. This study ran from January 2014 
to March 2016 at three CCTG-affiliated clinics in Southern California. Institutional Review 
Board approval was obtained at all institutions and informed consent was obtained from all 
participants included in the study.
Standardized assessments collected at baseline and annually were used to evaluate factors 
associated with successful retention in care and to evaluate the effect of an ALERT 
specialist. The primary endpoint was time to lost to follow up (LTFU), defined as no visit 
with a HIV provider at any of the three participating clinical sites for greater than 180 days 
as captured by chart review. Once the study endpoint was met, staff proceeded down an 
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algorithm to identify the location and status of participants. This algorithm included 
attempting all forms of contact: phone, email, letter to home, as well as searching public 
incarceration and death records. If participant were found to be incarcerated, they were 
censored at the time of incarceration. The protocol team debated on how to treat incarcerated 
participants and ultimately deemed them to be a separate category from LTFU. Incarcerated 
participants still have access to care while incarcerated within the prison system, but since 
incarceration is not volitional, participants cannot keep scheduled clinic appointments within 
the CCTG network. Because there was no way of knowing if these incarcerated participants 
would have kept their clinic appointments if not incarcerated, they were censored as stated 
above. Participants who established care with an outside HIV provider and did not consent 
for study staff to access outside clinic records were treated as LTFU.
Secondary endpoints were assessed through self-report at baseline, annually, and when 
primary endpoint was reached. These included known barriers to care such as HIV 
knowledge [38], PHQ-9 (Depression) [39], Self-Efficacy (adapted from Cancer Behavior 
Inventory Self-Efficacy scale) [40], Alcohol Use Disorders Identification Test (AUDIT-C) 
[41], tobacco, marijuana, and other drug use. We also evaluated by self-report endpoints that 
could contribute to ongoing HIV transmissions including number of sexual partners in past 3 
months, number of episodes of unprotected intercourse, intent to use condoms, 
determination to practice safe sex, and disclosure of HIV serostatus. Lastly, we collected 
additional clinical HIV outcomes by medical chart review: time to initiation of ART, viral 
suppression (defined as HIV RNA < 50 copies/mL), percentage and absolute CD4 T cell 
counts.
Subjects
Eligible participants were HIV-infected individuals 18 years or older, who were receiving 
HIV care services at one of the CCTG-affiliated clinics. This included persons new to care 
and returning to care (defined as not having a clinic visit for at least 180 days and a 
detectable HIV RNA). All participants were randomized and enrolled within 60 days of their 
initial clinic visit. Participants were either English or Spanish speakers.
Participants were randomized (1:1) to the ALERT Intervention Arm or SOC. Randomization 
was stratified by participant status as new or returning to care, and by HIV study site.
Intervention
Using the framework of the ‘Behavioral Model for Vulnerable Populations’ [15], we 
constructed a behavioral intervention aimed to improve engagement in care. This model 
posits that patient level factors [education (literacy), perception of HIV risk/diagnosis/
stigma, social support] and clinic level factors [available services on site (e.g., psychiatric), 
reminder phone calls] are critical barriers to engagement with healthcare [33, 42].
Participants in the ALERT arm received five coaching interventions. Topics included HIV 
health literacy, Navigating the Health Care System, Disclosure, Adherence, and Self-
Efficacy (Supplement Table 1). The coaching intervention was derived from outreach 
models previously proven to increase engagement and retention in HIV care [43, 44]. Each 
ALERT worker was trained to deliver the modules consistently to assure fidelity between 
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sites. Modules were standardized across study sites and there was regular study team calls 
between ALERT workers and supervising study investigators across study sites throughout 
the study period to assure consistency in module delivery.
Participants in the ALERT arm received reminder calls about upcoming appointments and 
follow up calls for missed visits. Engagement and retention efforts followed an algorithm 
developed in a pilot project [9]. Participants in the SOC arm received on-going clinic 
standards regarding out-reach and retention activity and once they reached LTFU, an 
ALERT worker would attempt to engage the participant to offer an End of Study visit. For 
participants who established care with an outside HIV provider, consent was obtained to 
access outside medical records for chart review and were not considered LTFU if they 
continued to engage in care, but if consent was not provided to access outside medical 
records, then were considered LTFU. Preferences for communication were elicited and 
included: text, voice message, phone call, and email. Participants also provided secondary 
contacts and included friends, family, partners, or other persons. All participants received 
monetary compensation of 20 dollars for completion of baseline visit and week 48 visit.
Statistical Analysis
Descriptive analyses were performed to compare demographic and baseline characteristics 
between study arms. Associations between categorical variables were analyzed using 
Fisher’s Exact Test, while associations between continuous variables were analyzed using 
the Wilcoxon Rank Sum Test.
Sample size calculations were based on a two-sided, two-sample log-rank test to compare 
the differences in time to the primary end point proportions between the intervention arm 
and the SOC arm. Since attrition is a component of the composite endpoint, attrition rates 
were not used as an adjustment in the power calculations. We developed the composite 
endpoint using data from national and local cascades of care that estimated the proportion of 
HIV positive patients who are HIV diagnosed and in care (ranging from 40 to 80%) [45, 46]. 
Based on this, we used 68% as a crude estimate for power. In our protocol, assuming 55 
subjects per group (for a total of 110 subjects), a two-year accrual and one-year follow up 
timeline, we calculated 81% power to detect a meaningful difference of 15%. This assumed 
a time without a composite endpoint rate of 68% in the SOC arm and that the intervention 
arm would increase the time without an endpoint to a rate of 83% (hazard ratio of 2.37). 
Analyses were stratified between persons new to care and returning to care. Secondary 
hypotheses were considered exploratory and were not a priori powered.
For the primary hypothesis, Kaplan-Meier curves and the log-rank test were used to 
determine if there was a difference in “time to LTFU” between treatment arms. Cox 
proportional hazards regression modeling was conducted to compare the time to LTFU 
between the two study arms adjusting for the following covariates: age, race and ethnicity. 
The following covariates were identified a priori with intent to include in the model if they 
were unbalanced by baseline and univariately associated with the outcome: education, 
income, AUDIT-C Score, alcohol use, tobacco use, marijuana use, any other illicit substance 
use, PHQ9 mood scale total score, HIV medication prescribed, and HIV Knowledge correct 
proportion.
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Since the study population was primarily men (93.1%), analyses were separately conducted 
on (a) all study participants and (b) the male subgroup. An analogous approach was applied 
on the secondary endpoint, “time to initiation of ART.”
For the other secondary outcomes descriptive analyses were conducted to compare study 
arms. All analyses were performed in the statistical software, R (version 3.1.1.). P-values 
less than 0.05 were considered statistically significant. As these were secondary outcomes of 
interest, there were no adjustments made for multiple comparisons.
Results
Baseline Characteristics of Study Participants
The characteristics of the study population are summarized in Tables 1 (for categorical 
variables) and 2 (for continuous variables), and consort presented in Fig. 1. A total of 116 
participants were enrolled, the majority were male 108 (93.1%) with 7 (6%) cis-women and 
1 (0.9%) trans-woman. The mean age was 38.3 years (SD = 11). Of the participants, 79 
(72.5%) were White, 10 (9%) Black, 3 (2.8%) Asian, 4 (3.7%) multiple race and 13 (11.9%) 
another race. Seventy-six participants (66.1%) were of Hispanic or Latino(a) ethnicity and 
82 (70.7%) said English was their primary language. Many participants had some college 
education 50 (43.1%), but most had low income with 71 (61.2%) reporting a household 
monthly average of < $2000, and 38 (32.8%) being unemployed. HIV transmission risk 
factors among participants included 88 (75.9%) reporting homosexual contact, 44 (37.9%) 
heterosexual contact, and 14 (12.1%) injection drug use. Risk factors were not mutually 
exclusive and thus participants were able to report multiple risks. The majority of 
participants were newly entering HIV care, 93 (80.2%), and many had been prescribed ART 
65 (56.5%) by study entry (study protocol allowed enrollment within 60 days of initial clinic 
visit thus some participants had already started ART).
Most participants reported their relationship status was “single” [75 (64.7%)] and disclosure 
to at least one person of HIV status was high (n = 93, 80.9%). Our population had high 
levels of alcohol (n = 70, 60.3%), tobacco (n=40, 34.5%), marijuana (n = 33, 28.5%) and 
other substance use (n = 54, 46.6%) (Table 1). However, the median baseline score on 
AUDIT-C was 3 (IQR: 0–5) suggesting participants were not, on average, hazardous alcohol 
drinkers (Table 2).
At baseline the mean CD4 T cell count was 327 cells/uL (SD = 244) with mean percent 
being 19.3 (SD = 10.2). Mean HIV viral load was 4.27 log10 copies/mL (SD = 1.22). There 
were no differences in baseline characteristics between participants randomized to the 
ALERT intervention and SOC.
Baseline demographics were also evaluated by site and as would be expected based on 
differences in population distribution in Southern California, some metrics did differ. Most 
notably one clinic in particular University of Southern California (USC) had a significantly 
greater proportion of Hispanic participants; 84.3% compared to University of California San 
Diego (UCSD) at 45.8% and Harbor-University of California Los Angeles (Harbor) at 
68.75% (p < 0.001). Participants at USC also demonstrated lower education (p = 0.002) and 
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lower household monthly income (p < 0.001) and were more likely to note Spanish as a 
primary language (p < 0.001). Participants at USC were also significantly less likely to use 
drugs 70.6% compared to 38.8% at UCSD and 42.75% at Harbor (p = 0.004) (data not 
shown).
Interestingly, UCSD had higher CD4 T cell counts at baseline (mean 445 cells/mL) 
compared to both Harbor and USC (207 and 250 cells/mL respectively, p < 0.001) and lower 
HIV viral loads (mean 3.73 log10 copies/mL) compared to Harbor and USC (mean 4.43 and 
4.73 copies/mL p < 0.001) (data not shown).
Impact of ALERT Specialist on LTFU
Of the 60 participants randomized into ALERT, 29 (48.3%) were LTFU compared to 24 
(42.9%) of the 56 participants in SOC. The median time to LTFU of ALERT subjects was 
81.7 weeks compared to 93.6 weeks for SOC (p = 0.49) (Fig. 2a). When adjusting for age, 
race, and ethnicity there was still no difference between the two arms (HR 1.27; 95% CI 
0.73, 2.22; p = 0.40). LTFU rates were not significantly different between the new to care 
and returning to care groups (43 vs. 56.5%, respectively) (P = 0.25). Participants in the 
ALERT intervention had a median of 3 visits (IQR: 1–4) compared to 2.5 (IQR: 1–3.25) in 
SOC before being LTFU (p = 0.43). This did not differ if participants were newly diagnosed 
or retuning to care [median 3 visits (IQR: 1.75–4.25) versus 2 (IQR: 1–3), respectively] (p = 
0.12). Of note LTFU rates were balanced between sites (data not shown).
Adherence to the intervention was as follows: 93% completed at least one, 83.3% at least 
two, 77% at least three, 73% at least four, and 60% all five modules.
Impact of ALERT Specialist on Secondary Outcomes of Interest
Fifty-seven participants were not on ART before baseline (27 in ALERT and 30 in SOC), of 
those 47 (82.5%) were newly diagnosed. In this population, we evaluated whether an 
ALERT specialist impacted time to ART initiation. The median time to ART in the ALERT 
group was 2 weeks compared to 3.6 weeks in SOC (p = 0.198) (Fig. 2b). Univariate analysis 
and multivariable Cox regression model found that the ALERT group initiated ART faster 
than SOC but not significantly (HR 1.45, 95% CI 0.81–2.6, p = 0.21) (Fig. 2b).
We evaluated the impact of the ALERT intervention on achieving suppressed HIV viral 
loads (defined as HIV RNA < 50 copies/mL) and the change in the absolute number and 
percentage of CD4 T cells over time. At week 24 a slightly higher proportion of participants 
randomized to the ALERT arm achieved an undetectable HIV viral load, but this was not a 
sustained at 48 weeks (Supplemental Table 2). There was no impact of the ALERT 
intervention on absolute or percentage of CD4 T cells (data not shown).
To investigate other outcomes of interest, we evaluated the impact of the ALERT 
intervention on HIV knowledge, depression, self-efficacy, use of alcohol, tobacco, 
marijuana, other drugs and on sexual risk practices at 48 weeks compared to SOC. No 
differences between arms were noted in HIV knowledge, self-efficacy, alcohol, tobacco, 
marijuana or other substances (data not shown).
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At 48 weeks, persons in the ALERT arm reported an increase from baseline in depressive 
symptoms compared to SOC (p = 0.02; Fig. 3).
There were no significant changes in the total number of partners, number of unprotected 
intercourse events, or attitudes about condom use in both arms from baseline to 48 weeks. 
Interestingly, persons in the ALERT arm reported more “strong agreement” in their 
determination to practice safe sex than SOC (p = 0.041) (Fig. 4a) but also lower rates of HIV 
disclosure to another person (vs. SOC) at week 48 (p = 0.032) (Fig. 4b).
To determine if the findings were influenced by differential attrition, we evaluated the 
baseline differences of participants with early discontinuation compared to those who 
completed the study. The majority of persons enrolled in the study (n = 116) had complete 
data (n = 106). The only statistically significant baseline demographic that differed between 
those who discontinued participation in the study early and those that completed the study 
was that all early discontinuers reported English as a primary language (p = 0.03) (data not 
shown). Additionally, completer and adherer sensitivity analyses did not impact study 
findings.
Discussion
This RCT evaluating enhanced outreach and health coaching by an ALERT worker revealed 
no impact on retention in care in HIV-infected persons new to or returning to care when 
compared to SOC in these academic HIV-specialty clinics. This was true despite differences 
between sites in baseline demographics. Of participants not on ART before baseline, there 
was a tendency to start ART faster in the ALERT arm versus SOC (2 weeks versus 3.6 
weeks), (p = 0.21). However, there were no differences in HIV knowledge, self-efficacy, 
alcohol, tobacco, marijuana or other substances at week 48.
Other studies utilizing different linkage and retention in care strategies demonstrate varying 
degrees of success. Project HOPE [35] enrolled hospitalized HIV-infected patients with 
active substance use and randomized them to patient navigation alone, patient navigation 
with financial incentives or SOC for 6 months. Both patient navigation arms included 
extensive contact with participants (up to 11 sessions) and like our study, used strength-
based and motivational interviewing approaches. However, at end of study there were no 
differences in viral suppression or death between the three arms at 48 weeks. LTFU rates 
were also similar between the three groups. Interestingly, a similar study evaluating 
enhanced contact, enhanced contact with skills building or SOC did show improved 
retention in both enhanced contact arms in six academically affiliated HIV primary care 
clinics [36]. This study evaluated significantly more participants (N = 1838) than ours which 
may suggest our intervention was underpowered to see an effect. Another study evaluated a 
care coordination program in Ryan White funded clinics in New York [29] that included 
outreach, multidisciplinary care team communication, patient navigation (including 
accompaniment to primary care visits), ART adherence support (including directly observed 
therapy) and structured health promotion. Outcomes in engagement in care and viral load 
suppression were significantly improved. Lastly, the District of Columbia evaluated the 
impact of a medical case management (MCM) program and found persons participating in 
Corado et al. Page 8
AIDS Behav. Author manuscript; available in PMC 2019 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
clinics with MCM were more likely to be retained in care, and virally suppressed [37]. All 
these studies utilized interventions that included patient education, empowerment, and 
facilitation of access to healthcare. Yet one model that reproduces consistent positive 
findings across differing populations of HIV infected has yet to be established.
Health coaching has demonstrated success in other chronic diseases such as diabetes 
mellitus, heart failure and chronic obstructive pulmonary disease [47–53] but did not impact 
participants in our study. Unlike other chronic diseases, HIV-infection is associated with 
high rates of co-occurring conditions that impact retention including substance use, mental 
health disorders and unemployment [54–56]. This was true in our study population that 
reported high rates of substance use, notably alcohol use (60%), and other drug use 
(excluding tobacco and marijuana use) (46.6%), although these did not appear problematic 
in most individuals as indicated by AUDIT-C and were not associated with LTFU. 
Additionally, nearly 33% of participants were unemployed with 61% reporting a household 
income of less than $2000 a month, which for a family of 3 or more is below the federal 
poverty level [57]. Unlike other chronic illnesses, HIV-infection may be asymptomatic, 
especially when the CD4 count is preserved [58, 59], which was often case in our study 
population with a mean CD4 count at baseline of 327 cells/uL. Thus, perhaps our 
participants were not yet symptomatic from HIV, as opposed to other chronic disease states 
such as heart failure, where poor adherence leads to immediate clinical change that 
motivates adherence and retention [60]. This study stratified participants according to 
whether they were new to care or returning to care, and a nonsignificant trend towards 
higher LTFU was observed in the returning to care group. It is possible that circumstances 
that caused the returning to care participants to have been LTFU prior to entering the study 
have not changed (i.e. homeless status, drug use) and thus contributed to continuing poor 
engagement in care. Lastly, all the clinic sites that participated in this study are 
multidisciplinary specialty HIV clinics with highly trained and experienced healthcare 
providers and staff that also provide access to case management and other ancillary services. 
Thus, the health coaching intervention offered by CCTG 594 may have overlapped with 
services already rendered in clinic. It is possible that health coaching would be more 
effective in a HIV-infected population with less specialty knowledge/ experience or access to 
ancillary services.
Other secondary outcomes of interest such as HIV knowledge, self-efficacy, alcohol, 
tobacco, marijuana or other substance use did not differ over the 48 weeks of study. Yet 
participants in the ALERT arm had higher week 48 depressive symptoms compared to those 
in standard of care. The reason for this change is unclear. It may be due to differences in the 
study populations that we did not capture. It is possible that repeated communication with 
research staff about HIV issues was a reminder to participants that they had HIV, which may 
have been inconsistent with the patient’s changing perspective on HIV and HIV self-
identification [59]. Or, participants in the ALERT arm were encouraged to discuss issues 
such as stigmatization, disclosure, and safe sex, which may have been difficult to process, 
resulting in higher rates of negative affect [61].
Participants in the ALERT intervention were more likely to report being motivated to 
practice safe sex, yet less likely to disclose HIV status. Consistent with previous studies, 
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discussing safe sex and risk for transmission may have led ALERT arm participants to 
strongly agree with practicing safe sex at week 48 [62]. Their hesitancy to disclose may be 
related to a higher rate of actual safe sex practices, or could have been associated with higher 
levels of depression as discussed above [63]. Alternatively, lower self-reported disclosure 
could reflect greater dissemination of the message that “undetectable=untransmittable” 
which participants in the ALERT arm could have used to justify non-disclosure [64].
This study had several limitations. First, persons in the ALERT arm demonstrated variable 
participation rates with 60% completing all five modules. Multiple attempts to optimize 
participation including trying to meet participants during scheduled HIV clinic appointment 
and modifications to the protocol that allowed module completion by phone were pursued 
but did not result in 100% completion. Unfortunately, because participants did not respond 
to multiple attempts at contact we could not capture reasons for not completing modules. It 
is possible that a more convenient or accessible approach may have had a beneficial effect. 
For example, a mobile technology approach (e.g. virtual health coach delivered via a mobile 
device) may address this concern. A second limitation of the study is that the majority of 
study participants were male, however analyses adjusted for gender did not change 
outcomes. A third limitation was the disproportionate recruitment of persons newly 
diagnosed compared to those returning to care which may have diluted the impact of the 
intervention. A fourth limitation is that during the study, two of the three participating clinics 
implemented a Medical Care Coordination Team, targeting the highest risk clinic patients, 
including those previously LTFU during the time of the study. This may have led to medical 
management burn out for the participants randomized to ALERT, or improved engagement 
in SOC. A fifth limitation is the possibility of misclassification of patients as LTFU. Lastly, 
linkage and engagement in care is impacted by multiple and complex factors that may have 
not been addressed by our intervention or modifiable within the time frame of the study, 
such as employment, transportation, and income.
Conclusion
It remains unknown how best to engage and retain patients who are new to and returning to 
care. In our RCT, enhanced contact, coaching and education did not enhance retention over 
the existing SOC in three HIV-specialty clinics. In fact, despite this very intensive 
intervention, LTFU rates were very high. Overcoming barriers to care and increasing 
engagement and retention remain challenges in HIV care. Future work should build on the 
lessons learned from CCTG 594, and focus on better understanding of clinic-specific and 
patient-specific factors that that contribute to poor engagement and retention. Delivering 
viral suppression as a standard of care for all will require more than outreach targeted at 
retention, but likely draw upon personalized medicine and social determinants to make the 
most impact.
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Fig. 1. 
Legend: Consort Figure
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Fig. 2. 
a The primary outcome of time to lost to follow up (LTFU) is represented using a Kaplan–
Meier Plot. At end of study there were no differences in the ALERT intervention arm 
compared to Standard of Care (SOC) (p = 0.487). b The secondary outcome of time to 
antiretroviral therapy (ART) initiation in persons not on ART at study entry did not differ 
between persons in the ALERT intervention compared to standard of care (p = 0.198)
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Fig. 3. 
Legend: From baseline to week 48, study participants in the ALERT arm reported slightly 
increased depression symptomatology based on PHQ-9 score while persons in standard of 
care (SOC) had decreases in depression symptomatology. The difference between the two 
arms was statistically significant (p = 0.02)
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Fig. 4. 
a Proportions of persons in ALERT compared to standard of care (SOC) arm (and overall 
summary) of attitudes regarding determination to practice safe sex. This was determined by 
asking the question “I am determined to practice safe sex” with a Likert scale of responses: 
strongly disagree, disagree, neutral, agree and strongly agree. At week 48 More persons in 
the ALERT arm were strongly determined to practice safe sex (p = 0.041). b Proportions of 
persons in ALERT compared to SOC arm (and overall summary) of HIV disclosure 
practices. At week 48 less persons in the ALERT arm reported disclosure of HIV compared 
to SOC (p = 0.032)
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Table 2
Baseline characteristics (continuous variables)
N Mean SD P value
Age (years)
 ALERT 60   39   11.0 0.316
 SOC 56   37.5   11.9
CD4 T cell percent
 ALERT 60   20.8   9.9 0.096
 SOC 55   17.7   10.3
CD4 T cell absolute count (cells/uL)
 ALERT 60 361.7 244.6 0.07
 SOC 56 289.6 240
CD8 T cell percent
 ALERT 59   54.4   12.5 0955
 SOC 55   54.2   12.9
CD8 T cell absolute count (cells/uL)
 ALERT 59 878.5 365 0.057
 SOC 55 782.7 392.9
HIV RNA (log10 copies/mL)
 ALERT 60   4.1   1.3 0.115
 SOC 56   4.4   1.1
HIV knowledge correct proportion
 ALERT 60   0.7   0.2 0.458
 SOC 56   0.8   0.2
Patient Health Questionnaire (PHQ-9)
 ALERT 60   7.7   6.4 0.769
 SOC 56   7.3   6.1
Self-Efficacy Subscale 1
 ALERT 60   2.4   0.5 0.387
 SOC 56   2.3   0.6
Self-Efficacy Subscale 2
 ALERT 60   2.3   0.7 0.294
 SOC 56   2.2   0.6
Self-Efficacy Subscale 3
 ALERT 60   2.3   0.7 0.97
 SOC 56   2.4   0.6
Alcohol used disorder identification test (AUDIT-C)
 ALERT 60   2.7   2.3 0.64
 SOC 56   3.4   3.5
ALERT active, linkage, engagement, retention, treatment, SOC standard of care, SD standard deviation
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